Interestingly, concurrent same-day colonoscopy was identified as a protective factor, with a lower risk of food retention (OR 0.18, p -value = 0.003) in patients undergoing both EGD and colonoscopy [29]
Liu WJ, Jin HY, Lee KA, Xie SH, Baek HS, Park TS (2011) Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
Craving Support Many patients ask about Tirzepatide because they struggle with cravings, overeating, or food noise
An overview of expected approval dates for weight loss medications currently in clinical trials Oral Semaglutide: A New Daily Weight Loss Tablet Oral semaglutide, a groundbreaking weight loss drug, is classified as a GLP-1 agonist and is set to transform the landscape of obesity treatment
GLP-1 Goes For The Middle Indian drugmakers are set to dominate the GLP-1 market
the results are shown in Fig